The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations

HCV screening depends mainly on a one-assay anti-HCV testing strategy that is subject to an increased false-positive rate in low-prevalence populations. In this study, a two-assay anti-HCV testing strategy was applied to screen HCV infection in two groups, labelled group one (76,442 people) and grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yanfang, Pan, Huifen, Gao, Qin, Lv, Panpan, Xu, Xiaoqin, Zhao, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062551/
https://www.ncbi.nlm.nih.gov/pubmed/33888806
http://dx.doi.org/10.1038/s41598-021-88138-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062551/
https://www.ncbi.nlm.nih.gov/pubmed/33888806
http://dx.doi.org/10.1038/s41598-021-88138-2

Ejemplares similares